OM Earnings & Financial Statements
Outset Medical, Inc.
$3.84
-$0.22(-5.42%)
55
Overall
60
Value
50
Tech
55
Quality
Market Cap
$72.18M
Volume
80.02K
52W Range
$2.84 - $15.94
Target Price
$7.67
OM earnings and financial statements: Outset Medical, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
OM Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $119.48M | $113.69M | $130.38M | $115.38M | $102.60M |
| Cost of revenue | $72.72M | $75.13M | $101.38M | $97.54M | $94.99M |
| Operating income | -$66.71M | -$113.38M | -$169.77M | -$161.02M | -$130.52M |
| EBITDA | -$62.64M | -$97.89M | -$153.79M | -$153.93M | -$124.86M |
| Net income | -$81.65M | -$127.98M | -$172.80M | -$162.96M | -$131.94M |
| EPS (diluted) | $-5.37 | $-36.90 | $-52.20 | $-50.70 | $-43.35 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $264.50M | $275.80M | $313.80M | $400.12M | $463.46M |
| Total liabilities | $137.54M | $248.98M | $190.91M | $154.13M | $89.38M |
| Shareholders’ equity | $126.95M | $26.82M | $122.89M | $245.99M | $374.08M |
| Cash and equivalents | $35.01M | $124.01M | $68.51M | $73.22M | $182.35M |
| Long-term debt | $99.51M | $200.06M | $134.59M | $101.91M | $36.66M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$46.33M | -$116.30M | -$131.37M | -$145.73M | -$130.26M |
| Capital expenditure | -$798.0K | -$912.0K | -$3.44M | -$8.32M | -$3.11M |
| Free cash flow | -$47.13M | -$117.22M | -$134.81M | -$154.05M | -$133.37M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OM | $3.84 | -5.4% | 80.02K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |